Diatron Group
Diatron is a portfolio company of The Riverside Company, a global private equity firm focused on acquiring growing businesses valued at up to $200 million (€200 million in Europe). Founded in 1988, Riverside’s international portfolio now includes 80 companies, and it has more than $3 billion/€2.5 billion in assets under management.
Diatron’s vision since the company’s foundation in 1989, is to become a worldwide leader in-vitro diagnostics, providing customers with a broad portfolio of high-quality tailored solutions. In its new production facility in Budapest, Hungary, the extensive R&D/Engineering team develops and manufactures compact hematology and clinical chemistry analyzers and reagents for the human medical and veterinary markets.
